591 POSTER Antitumor activity of PLX4032, a selective V600EB-Raf inhibitor, as monotherapy and in combination with capecitabine ± bevacizumab in a colorectal cancer xenograft model

Autor: Kolinsky, K., Bollag, G., Lee, R., Packman, K., Heimbrook, D., Su, F., Higgins, B.
Zdroj: In EJC Supplements 2008 6(12):185-185
Databáze: ScienceDirect